Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
Canada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company
Read moreCanada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company
Read moreCanada NewsWire Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ( $30.5 million CAD) for
Read moreCanada NewsWire BEIJING , March 22, 2021 /CNW/ — Nanjing Jiangbei New Area , a state-level new area in east
Read moreCanada NewsWire MONTREAL , March 16, 2021 /CNW/ – Amgen announced today that it has entered into a multi-year partnership
Read moreXevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous
Read more